| 标题 |
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Rachel M. Layman; Hyo S. Han; Hope S. Rugo; Erica Stringer-Reasor; Jennifer M. Specht; et al 出版日期:2024-03-25 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)